Video

A New Decade Of Outsourcing: What Can We Expect? - Advice from Shawn Eisenberg, Executive Director, Manufacturing & Supply Chain, ImmunoGen

Source: Outsourced Pharma

Will the "Twenty-Twenties" be as exciting as they sound for our industry? For certain, nobody saw a coronavirus outbreak put outsourcing in such a public light.

Outsourced Pharma hosted a live, virtual discussion in June 2020 focusing on four key areas: continuous manufacturing; cell and gene therapy influences; new sponsor-CDMO service models; and "Supply Chain 4.0."

Here are excerpts from the opening comments of one of our speakers,Shawn Eisenberg, Executive Director, Manufacturing & Supply Chain, ImmunoGen.

VIEW THE VIDEO!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma